ARCHIVES

Zevalin Regimen Effective In Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

DCPC Advisors Okay Continuation of Children’s Diet Study

January 31, 1992

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

August 13, 2004

In Brief: Susumu Tonegawa To Receive Bristol-Myers Award; Mark Green Named Director Of UCSD Cancer Center

March 7, 1986

Dipersio Is Chief Of Oncology At Washington University.

July 14, 2000

Grants & Contracts: NCI Workshop Informs Historically Black Institutions About Funding Process

October 10, 1997